1. Home
  2. CPA vs AXSM Comparison

CPA vs AXSM Comparison

Compare CPA & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Copa Holdings S.A.

CPA

Copa Holdings S.A.

HOLD

Current Price

$131.17

Market Cap

5.1B

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$176.82

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPA
AXSM
Founded
1947
2012
Country
Panama
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
9.0B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
CPA
AXSM
Price
$131.17
$176.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
20
Target Price
$157.80
$183.10
AVG Volume (30 Days)
246.4K
728.5K
Earning Date
02-11-2026
02-17-2026
Dividend Yield
4.92%
N/A
EPS Growth
6.63
N/A
EPS
16.07
N/A
Revenue
$3,533,554,000.00
$561,263,000.00
Revenue This Year
$6.26
$66.40
Revenue Next Year
$10.65
$56.13
P/E Ratio
$8.15
N/A
Revenue Growth
1.53
65.83
52 Week Low
$82.54
$79.19
52 Week High
$133.00
$184.40

Technical Indicators

Market Signals
Indicator
CPA
AXSM
Relative Strength Index (RSI) 67.13 66.91
Support Level $125.00 $165.75
Resistance Level $132.27 $184.40
Average True Range (ATR) 2.80 7.05
MACD 1.13 1.08
Stochastic Oscillator 86.33 79.11

Price Performance

Historical Comparison
CPA
AXSM

About CPA Copa Holdings S.A.

Copa Holdings SA is a provider of airline passenger and cargo services through its subsidiaries. The company operates through the air transportation segment. It offers international air transportation for passengers, cargo, and mail, operating from its Panama City hub in the Republic of Panama, and domestic and international air transportation for passengers, cargo, and mail with a point-to-point route network through Copa Colombia, a Colombian air carrier. The company's geographical segments are North America, South America, Central America, and the Caribbean. It derives the maximum revenue from North America.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: